CN108853373A - 一种治疗皮肤湿疹的膏剂及其制备方法 - Google Patents
一种治疗皮肤湿疹的膏剂及其制备方法 Download PDFInfo
- Publication number
- CN108853373A CN108853373A CN201810997448.3A CN201810997448A CN108853373A CN 108853373 A CN108853373 A CN 108853373A CN 201810997448 A CN201810997448 A CN 201810997448A CN 108853373 A CN108853373 A CN 108853373A
- Authority
- CN
- China
- Prior art keywords
- camphor
- preparation
- paste
- cera alba
- albolene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 22
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 24
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 22
- 229930008380 camphor Natural products 0.000 claims abstract description 22
- 229960000846 camphor Drugs 0.000 claims abstract description 21
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000007765 cera alba Substances 0.000 claims abstract description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011787 zinc oxide Substances 0.000 claims abstract description 10
- 239000010632 citronella oil Substances 0.000 claims abstract description 8
- 239000004615 ingredient Substances 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 230000007721 medicinal effect Effects 0.000 claims description 3
- 239000011265 semifinished product Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000004577 thatch Substances 0.000 claims description 3
- RRTCFFFUTAGOSG-UHFFFAOYSA-N benzene;phenol Chemical compound C1=CC=CC=C1.OC1=CC=CC=C1 RRTCFFFUTAGOSG-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000002574 poison Substances 0.000 abstract description 2
- 231100000614 poison Toxicity 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 15
- 239000003814 drug Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal group Chemical group CC(CC=O)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229930003633 citronellal Natural products 0.000 description 2
- 235000000983 citronellal Nutrition 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- HQVZOORKDNCGCK-UHFFFAOYSA-N 2-[(2,4-dichlorophenyl)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(CC=2C(=CC(Cl)=CC=2)Cl)=C1 HQVZOORKDNCGCK-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 244000299492 Thespesia populnea Species 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 235000009932 Zanthoxylum simulans Nutrition 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000011499 joint compound Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- LPEBYPDZMWMCLZ-CVBJKYQLSA-L zinc;(z)-octadec-9-enoate Chemical compound [Zn+2].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O LPEBYPDZMWMCLZ-CVBJKYQLSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗皮肤湿疹的膏剂及其制备方法,其成分由香茅油0.1‑2%、苯酚1‑5%、樟脑1‑5%、氧化锌15‑35%、白蜂蜡1‑5%、白凡士林50‑80%、黄芩1‑5%、黄柏1‑5%组成。并依次取原料,制备完成后出料,对治疗皮肤湿毒,湿疹有明显的效果。
Description
技术领域
本发明是一种治疗皮肤湿疹的膏剂及其制备方法,主要作用于皮肤湿疹的治疗。
背景技术
湿疹是由多种内外因素引起的瘙痒剧烈的一种皮肤炎症反应,分急性、亚急性、慢性三期。急性期具渗出倾向,慢性期则浸润、肥厚。有些病人直接表现为慢性湿疹。皮损具有多形性、对称性、瘙痒和易反复发作等特点。目前西医对湿疹尚无特效疗法,多采用对症治疗。以内服抗组胺药物治疗为多,外用药剂型依据临床皮损表现而定,如红肿明显,渗出多者应选溶液冷湿敷,红斑、丘疹时可用洗剂、乳剂、泥膏、油剂等;呈水疱、糜烂者需用油剂;普遍存在药效不明显、副作用大等问题。
发明内容
基于此,有必要针对以上所提出的缺点,提出一种治疗皮肤湿疹的膏剂及其制备方法。
一种治疗皮肤湿疹的膏剂,其成分由以下重量比组成:香茅油0.1-2%、苯酚1-5%、樟脑1-5%、氧化锌15-35%、白蜂蜡1-5%、白凡士林50-80%、黄芩1-5%、黄柏1-5%。
优选地,一种治疗皮肤湿疹的膏剂,其成分由以下重量比组成:香茅油1.5%、苯酚2.5%、樟脑4%、氧化锌24%、白蜂蜡4%、白凡士林58%、黄芩3%、黄柏3%。
一种治疗皮肤湿疹的膏剂及其制备方法,包括以上成分外,其制备方法由以下步骤完成:
(1)各选取配方量的黄柏、黄芩去除杂质和非药用部分,加水在98~100℃的温度下煎煮1-3次,每次煎煮1-3小时,合并煎液,滤过,煎液浓缩至40-60℃测相对密度为1.05-1.15的清膏,待冷至室温,加乙醇使含醇量为50-70%,搅匀,冷藏24-72小时,取上清液,过滤,滤液回收乙醇,浓缩至45-60℃测相对密度1.20-1.40,得混合液A;
(2)依次取配方量的白蜂蜡、樟脑于一容器中进行溶解,溶解完全后得混合液B;
(3)将配方量的白凡士林加入乳化锅中,加热到42℃后,依次加入混合液A、混合液B、香茅油、苯酚、氧化锌,搅拌速度25转/分钟,保温20分钟,其中每10分钟乳化均质一次,共2次,抽真空,然后开始冷却降温,取半成品送检,送检合格后出料;
(4)出料后装瓶成为成品。
作为上述技术方案的进一步优化,所述步骤(2)中,白蜂蜡、樟脑于一容器中进行溶解时,加入搅拌棒进行搅拌,搅拌速度为30转/分钟,搅拌时间10-15分钟。
本发明的一种治疗皮肤湿疹的膏剂及其制备方法,通过上述设置,对治疗皮肤湿毒,湿疹,借伤成腐,烂脚趾甲有特效,特别对皮肤湿疹治疗率高。
具体实施方法:
本发明一实施例提供的一种治疗皮肤湿疹的膏剂及其制备方法。
一种实施例中,一种治疗皮肤湿疹的膏剂,其成分由以下重量比组成:香茅油1.5%、苯酚2.5%、樟脑4%、氧化锌24%、白蜂蜡4%、白凡士林58%、黄芩3%、黄柏3%。
本发明所述的原料药介绍如下:
香茅油:又称香草油或雄刈萱油。由香茅的全草经蒸汽蒸馏而得。淡黄色液体。有浓郁的山椒香气。主要成分是香茅醛、香叶醇和香茅醇。用于提取香茅醛,供合成羟基香茅醛、香叶醇和薄荷脑。也可用作杀虫剂、驱蚊药和皂用香料。
苯酚:苯酚为消毒防腐剂,具有杀菌、止痒作用。
樟脑:为樟科植物樟的枝、干、叶及根部,经提炼制得的颗粒状结晶。粗樟脑通常在冬季加工用50年生以上樟树树干和根为原料,削成薄片后在木甑中隔水蒸馏,樟脑和樟脑油随水蒸气馏出,冷凝所得白色晶体为粗樟脑,油状液体为樟脑油。总得率2.0~2.5%。粗樟脑精制有吹风升华法和连续分馏升华法两种方法。中国以吹风升华法为主。粗樟脑先经离心机除去油和水,放入升华锅熔融、升华,樟脑蒸气随锅顶吹入的空气一起引入第1升华室,控制冷却温度得粉状结晶成品。随后进入第2、第3升华室的馏分,因控制温度较低,沸点低于樟脑的水分和油分随同少量樟脑蒸气在此冷凝结晶,为樟脑粗品(含油水8%以上),需重新升华精制。中国天然精制樟脑有粉状和块状两种。质量符合各国药典规格:熔点174~179℃,比旋度厍+41°~+43°(20%于乙醇中),不挥发物0.05%以下,水分符合1克加石油醚10毫升澄清溶解。
氧化锌:具有较弱的收敛及抗菌作用。能与油脂中的游离脂肪酸生成油酸锌及脂酸锌,对皮肤起保护作用;也通过毛囊吸收到细胞内,促进核酸和核蛋白的合成,参与细胞的能量代谢,起到促进组织修复的作用。临床适用于恶急性皮炎、湿疹等。
白蜂蜡:白蜂蜡可以广泛用于药物的生产中,它可以增加一些药用乳膏的粘稠度,也可以起稳定药性的作用,另外在白蜂蜡还是制成药物糖衣的重要原料。还有控制药物吸收的作用,是那些缓释药物最理想的外膜,它可以避免药物在胃部吸收,让它进入肠道以后才会发挥自己的功效。广泛运用于化妆品中。
白凡士林:白凡士林系从石油中得到的多种烃的半固体混合物,外观为白色或微黄色均匀的软膏状物。具防水性,是一种非常好的保湿用品,用于配制医药的药膏及皮肤保护油膏用的原料;化妆品乳膏、香脂化妆油等的配料;纺织工业润滑丝织品用的乳化膏;精密仪器及医疗器械的临时防护。也可用作橡胶制品的软化剂。
黄柏:为芸香科植物黄皮树或黄檗的干燥树皮。前者习称“川黄柏”,后者习称“关黄柏”。可入药,性味苦寒,有清热燥湿,泻火除蒸,解毒疗疮之功效。
黄芩:有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。
一种实施例中,一种治疗皮肤湿疹的膏剂及其制备方法,其制备方法由以下步骤完成:
(1)各选取配方量的黄柏、黄芩去除杂质和非药用部分,加水在98~100℃的温度下煎煮1-3次,每次煎煮1-3小时,合并煎液,滤过,煎液浓缩至40-60℃测相对密度为1.05-1.15的清膏,待冷至室温,加乙醇使含醇量为50-70%,搅匀,冷藏24-72小时,取上清液,过滤,滤液回收乙醇,浓缩至45-60℃测相对密度1.20-1.40,得混合液A;
(2)依次取配方量的白蜂蜡、樟脑于一容器中进行溶解,溶解完全后得混合液B;
(3)将配方量的白凡士林加入乳化锅中,加热到42℃后,依次加入混合液A、混合液B、香茅油、苯酚、氧化锌,搅拌速度25转/分钟,保温20分钟,其中每10分钟乳化均质一次,共2次,抽真空,然后开始冷却降温,取半成品送检,送检合格后出料;
(4)出料后装瓶成为成品。
一种实施例中,所述步骤(2)中,白蜂蜡、樟脑于一容器中进行溶解时,加入搅拌棒进行搅拌,搅拌速度为30转/分钟,搅拌时间10-15分钟。在本实施例中,搅拌时间具体为10分钟。
本发明的剂型:膏剂,10.4g。
本发明的使用方法:将患处洗净,将药膏涂以药棉或油纸敷上,每日三次至四次。
以上所述实施例的各技术特征可以进行任意的组合,为使描述简洁,未对上述实施例中的各个技术特征所有可能的组合都进行描述,然而,只要这些技术特征的组合不存在矛盾,都应当认为是本说明书记载的范围。
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。
Claims (4)
1.一种治疗皮肤湿疹的膏剂,其特征在于,成分由以下重量比组成:香茅油0.1-2%、苯酚1-5%、樟脑1-5%、氧化锌15-35%、白蜂蜡1-5%、白凡士林50-80%、黄芩1-5%、黄柏1-5%。
2.根据权利要求1所述的膏剂,其特征在于,成分由以下重量比组成:香茅油1.5%、苯酚2.5%、樟脑4%、氧化锌24%、白蜂蜡4%、白凡士林58%、黄芩3%、黄柏3%。
3.根据权利要求2所述的膏剂的制备方法,其特征在于,其制备方法由以下步骤完成:
(1)各选取配方量的黄柏、黄芩去除杂质和非药用部分,加水在98~100℃的温度下煎煮1-3次,每次煎煮1-3小时,合并煎液,滤过,煎液浓缩至40-60℃测相对密度为1.05-1.15的清膏,待冷至室温,加乙醇使含醇量为50-70%,搅匀,冷藏24-72小时,取上清液,过滤,滤液回收乙醇,浓缩至45-60℃测相对密度1.20-1.40,得混合液A;
(2)依次取配方量的白蜂蜡、樟脑于一容器中进行溶解,溶解完全后得混合液B;
(3)将配方量的白凡士林加入乳化锅中,加热到42℃后,依次加入混合液A、混合液B、香茅油、苯酚、氧化锌,搅拌速度25转/分钟,保温20分钟,其中每10分钟乳化均质一次,共2次,抽真空,然后开始冷却降温,取半成品送检,送检合格后出料;
(4)出料后装瓶成为成品。
4.根据权利要求3所述的制备方法,其特征在于,所述步骤(2)中,白蜂蜡、樟脑于一容器中进行溶解时,加入搅拌棒进行搅拌,搅拌速度为30转/分钟,搅拌时间10-15分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810997448.3A CN108853373A (zh) | 2018-08-30 | 2018-08-30 | 一种治疗皮肤湿疹的膏剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810997448.3A CN108853373A (zh) | 2018-08-30 | 2018-08-30 | 一种治疗皮肤湿疹的膏剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108853373A true CN108853373A (zh) | 2018-11-23 |
Family
ID=64322422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810997448.3A Pending CN108853373A (zh) | 2018-08-30 | 2018-08-30 | 一种治疗皮肤湿疹的膏剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108853373A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112386566A (zh) * | 2019-08-15 | 2021-02-23 | 天津金耀药业有限公司 | 一种樟脑软膏 |
-
2018
- 2018-08-30 CN CN201810997448.3A patent/CN108853373A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112386566A (zh) * | 2019-08-15 | 2021-02-23 | 天津金耀药业有限公司 | 一种樟脑软膏 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8449924B2 (en) | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds | |
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
HU202743B (en) | Active ingredient composition comprising medicinal herb extracts, cosmetics comprising such active ingredient and process for producing medicinal and veterinary compositions | |
CN107349149A (zh) | 一种祛痘精华液及其制备方法 | |
CN104940050A (zh) | 沉香挥发油原液在制备护肤品中的用途 | |
CN103356443A (zh) | 牙膏 | |
CN106466331A (zh) | 包含黄漆木萃取物的组合物 | |
CN102961282A (zh) | 具有促渗透作用的组合物及其制备方法和应用 | |
CN104055817A (zh) | 一种具有镇静功效的组合物及其雾化制剂 | |
CN104922248A (zh) | 一种抗菌、消炎中药复方凝胶剂及制备方法 | |
JPH0616530A (ja) | 化粧料 | |
JPH01172331A (ja) | 家畜のパスツレラヘモリティカ感染症の予防及び治療剤 | |
CN108524887A (zh) | 一种灰指甲药膏及其制备方法 | |
CN108853373A (zh) | 一种治疗皮肤湿疹的膏剂及其制备方法 | |
CN106581303A (zh) | 一种防止反复性口腔溃疡的漱口水 | |
US6541163B1 (en) | Process of powder for bath from natural plants | |
CN100486636C (zh) | 治疗牙齿敏感证的糊剂及其制备方法 | |
CN107485648A (zh) | 猴桃标白猴薄荷油外用组合物及其制备方法 | |
KR20060074038A (ko) | 아토피성 피부염의 예방 효과를 가지는 조성물 | |
CN108938794A (zh) | 一种驱风止痛的外用剂及其制备方法 | |
CN109223868A (zh) | 一种祛湿疹精油膏及其制备方法 | |
CN108619410A (zh) | 一种艾山灵艾艾草精油及其提取工艺 | |
CN107929624A (zh) | 一种治疗脚气的药膏及其制备方法 | |
Postoy et al. | Research about development of drugs from white willow bark and sage | |
CN101991616B (zh) | 一种用于冠心病心绞痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181123 |
|
WD01 | Invention patent application deemed withdrawn after publication |